Alan Milinazzo - CAS Medical Director

Director

Mr. Alan W. Milinazzo is Director of the Company. He is currently President and Chief Executive Officer of InspireMD, Inc., a publiclytraded interventional device company focused on developing novel embolic protection products, where he has served since 2013. From 2005 to 2012, he served as Chief Executive Officer and Director of Orthofix International, N.V., a publiclytraded global orthopedic company. From 2002 to 2005 he served as Vice President of the vascular business as well as Vice President and G.M. of the coronary and peripheral businesses at Medtronic Inc. Mr. Milinazzo also served in executive positions at Boston Scientific Corporationrationration. In addition to being a board member of InspireMD, Inc., he also serves on the board of the Musculoskeletal Transplant Foundation. He formerly served on the boards of Orthofix International, N.V., Medpace, and HET Systems since 2015.
Age 57
Tenure 9 years
Phone203-488-6056
Webhttp://www.fore-sight.com
Milinazzo graduated cum laude from Boston College. He is an experienced senior executive and board director, developing high growth, profitable, global healthcare businesses, including biologics and therapeutic devices. With his expertise in management and marketing within the healthcare industry, Mr. Milinazzo provides the Board the expanded ability to evaluate key decisions on business development and operations.

CAS Medical Management Efficiency

The company has return on total asset (ROA) of (23.57) % which means that it has lost $23.57 on every $100 spent on assets. This is way below average. CAS Medical's management efficiency ratios could be used to measure how well CAS Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 9.38 M in liabilities. CAS Medical Systems has a current ratio of 2.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist CAS Medical until it has trouble settling it off, either with new capital or with free cash flow. So, CAS Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CAS Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CAS to invest in growth at high rates of return. When we think about CAS Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Boaz GorfungSpace Communication
45
Jeffrey GrahamNETGEAR
62
Javier SuarezBBB Foods
47
Paul HanrahanAlbertsons Companies
57
Pablo GrattarolaBBB Foods
51
Wendy NeedhamGenuine Parts Co
67
John JohnsGenuine Parts Co
69
Bracha PolskyLitvakSpace Communication
61
Uziel DaninoSpace Communication
59
Richard NavarreAlbertsons Companies
George MorrisAlbertsons Companies
59
Aviel TenenbaumSpace Communication
50
Mary BullockGenuine Parts Co
70
Donna HylandGenuine Parts Co
60
Diego ApalateguiBBB Foods
47
Mike BeebeTyson Foods
74
David FreudenthalAlbertsons Companies
64
Elizabeth CampGenuine Parts Co
69
James SabalaAlbertsons Companies
60
Ziv LeitmanSpace Communication
58
Patrick KriegshauserAlbertsons Companies
54
CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut. CAS Medical operates under Medical Instruments Supplies classification in USA and is traded on BATS Exchange. It employs 73 people. CAS Medical Systems (CASM) is traded on NASDAQ Exchange in USA and employs 73 people.

Management Performance

CAS Medical Systems Leadership Team

Elected by the shareholders, the CAS Medical's board of directors comprises two types of representatives: CAS Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CAS. The board's role is to monitor CAS Medical's management team and ensure that shareholders' interests are well served. CAS Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CAS Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kenneth Weisshaar, Independent Director
Jeffrey Baird, CFO, Secretary
Kimberly Strusky, Executive Vice President - U.S. Sales
Don Markley, IR Contact Officer
Paul Benni, Chief Scientific Officer
Kathleen Tune, Independent Director
Paul Molloy, Director
James Thomas, Lead Independent Director
Thomas Patton, President CEO, Director
John Gamelin, VP of RandD
Gregory Rainey, Independent Director
Alan Milinazzo, Director

CAS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CAS Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CAS Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAS Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAS Medical will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Tenet Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tenet Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tenet Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tenet Healthcare to buy it.
The correlation of Tenet Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tenet Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tenet Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tenet Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in CAS Stock

If you are still planning to invest in CAS Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CAS Medical's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk